Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression.
Hossain DMS, Javaid S, Cai M, Zhang C, Sawant A, Hinton M, Sathe M, Grein J, Blumenschein W, Pinheiro EM, Chackerian A.
Hossain DMS, et al. Among authors: chackerian a.
J Clin Invest. 2018 Feb 1;128(2):644-654. doi: 10.1172/JCI94586. Epub 2018 Jan 16.
J Clin Invest. 2018.
PMID: 29337311
Free PMC article.